Skip to content
1887

Access Microbiology open research platform logo Access Microbiology

Volume 2, Issue 12

High levels of toxigenic contamination of hospital environments: a hidden threat in hospital-acquired infections in Kenya Open Access

Abstract

The contribution of (formerly ) to the burden of hospital-associated infections (HAIs) remains undetermined in many African countries.

This study aimed to identify a sensitive and readily adaptable detection assay and to evaluate the HAI risk in Kenya.

Sterile swabs in neutralizing buffer were used to sample equipment or surfaces that patients and clinical staff touched frequently. These swabs were either plated directly on chromogenic agar or cultured in an enrichment broth before plating. The swab suspensions, enrichment broth and plate cultures were screened by quantitative PCR (qPCR) to determine the most efficient detection method. The HAI risk was evaluated by testing the -positive samples by qPCR for the A, B and binary toxins.

was detected on 4/57 (7.0 %) equipment and surfaces by direct culture. The additional enrichment step increased the detection rate 10-fold to 43/57 (75.4 %). In total, 51/57 (89.5 %) environmental samples were positive for detected through either culture or qPCR. The genes encoding the primary toxins, and , were detected on six surfaces, while the genes encoding the binary toxins, and , were detected on 2/57 (3.5 %) and 3/57 (5.3 %) surfaces, respectively. Different toxin gene profiles were detected: the − gene profile on 4/10 (40 %) high-touch surfaces, + on 3/10 (30 %) surfaces, on 2/10 (20 %) surfaces and on one high-touch surface.

The widespread contamination of hospital environments by toxigenic gives a strong indication of the high risk of infections (CDIs). The two-step culture process described can easily be adapted for monitoring hospital environment contamination by .

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): hospital environments , hospital-acquired infections and toxigenic Clostridioides difficile
Funding
This study was supported by the:
  • Armed Forces Health Surveillance Branch (US),Global Emerging Infections Surveillance and Research Section (Award P008017KY1.1.2)
    • Principle Award Recipient: Lillian Musila
© 2020 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000171
2020-09-18
2025-01-21
Loading full text...

Full text loading...

/deliver/fulltext/acmi/2/12/acmi000171.html?itemId=/content/journal/acmi/10.1099/acmi.0.000171&mimeType=html&fmt=ahah

References

  1. Kim KH, Fekety R, Batts DH, Brown D, Cudmore M et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981; 143:42–50 [View Article]
     [Google Scholar]
  2. Davies KA, Longshaw CM, Davis GL, Bouza E, Barbut F et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis 2014; 14:1208–1219 [View Article]
     [Google Scholar]
  3. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015; 372:825–834 [View Article]
     [Google Scholar]
  4. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005; 18:247–263 [View Article]
     [Google Scholar]
  5. Ocan M, Obuku EA, Bwanga F, Akena D, Richard S et al. Household antimicrobial self-medication: a systematic review and meta-analysis of the burden, risk factors and outcomes in developing countries. BMC Public Health 2015; 15:1–11 [View Article]
     [Google Scholar]
  6. Troeger C, Forouzanfar M, Rao PC, Khalil I, Brown A et al. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the global burden of disease study 2015. Lancet Infect Dis 2017; 17:909–948 [View Article]
     [Google Scholar]
  7. Keeley AJ, Beeching NJ, Stott KE, Roberts P, Watson A et al. Clostridium difficile: A healthcare-associated infection of unknown significance in adults in sub-Saharan Africa. Mal Med J 2016; 28:66 [View Article]
     [Google Scholar]
  8. Gerding DN, Johnson S, Rupnik M, Aktories K. Mechanism, epidemiology, and potential clinical importance Clostridium difficile binary toxin CDT. Gut Microbes 2014; 5:15–27
     [Google Scholar]
  9. Mwachari C, Batchelor BIF, Paul J, Waiyaki PG, Gilks CF. Chronic diarrhoea among HIV-infected adult patients in Nairobi, Kenya. J Infect 1998; 37:48–53 [View Article]
     [Google Scholar]
  10. Zulu I, Kelly P, Mwansa J, Veitch A, Farthing MJ. Contrasting incidence of Clostridium difficile and other enteropathogens in AIDS patients in London and Lusaka. Trans R Soc Trop Med Hyg 2000; 94:167–168 [View Article]
     [Google Scholar]
  11. Samie A, Obi CL, Franasiak J, Archbald-Pannone L, Bessong PO et al. PCR detection of Clostridium difficile triose phosphate isomerase (tpi), toxin A (tcdA), toxin B (tcdB), binary toxin (cdtA, cdtB), and tcdC genes in Vhembe district, South Africa. Am J Trop Med Hyg 2008; 78:577–585 [View Article][PubMed]
     [Google Scholar]
  12. Onwueme K, Fadairo Y, Idoko L, Onuh J, Alao O et al. High prevalence of toxinogenic Clostridium difficile in Nigerian adult HIV patients. Trans R Soc Trop Med Hyg 2011; 105:667–669 [View Article]
     [Google Scholar]
  13. Seugendo M, Janssen I, Lang V, Hasibuan I, Bohne W et al. Prevalence and strain characterization of Clostridioides (Clostridium) difficile in representative regions of Germany, Ghana, Tanzania and Indonesia - a comparative multi-center cross-sectional study. Front Microbiol 1843; 2018:9
     [Google Scholar]
  14. Rajabally N, Kullin B, Ebrahim K, Brock T, Weintraub A et al. A comparison of Clostridium difficile diagnostic methods for identification of local strains in a South African centre. J Med Microbiol 2016; 65:320–327 [View Article]
     [Google Scholar]
  15. Kullin BR, Reid S, Abratt V. Clostridium difficile in patients attending tuberculosis hospitals in Cape Town, South Africa, 2014–2015. Afr J Lab Clin Med 2018; 7:9 [View Article]
     [Google Scholar]
  16. Oyaro MO, Plants-Paris K, Bishoff D, Malonza P, Gontier CS et al. High rate of Clostridium difficile among young adults presenting with diarrhea at two hospitals in Kenya. Int J Infect Dis 2018; 74:24–28 [View Article]
     [Google Scholar]
  17. Roldan GA, Cui AA, Pollock NR. Assessing the burden of Clostridium difficile infection in low- and middle-income countries. J Clin Microbiol 2018; 56:01747–17 [View Article]
     [Google Scholar]
  18. Nejad SB, Allegranzi B, Syed SB, Ellis B, Pittet D. Health-care-associated infection in Africa: a systematic review. Bull World Heal Organ 2011; 89:757–765 [View Article]
     [Google Scholar]
  19. Kaatz GW, Gitlin SD, Schaberg DR, Wilson KH, Kauffman CA et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988; 127:1289–1294 [View Article]
     [Google Scholar]
  20. Guerrero DM, Nerandzic MM, Jury LA, Jinno S, Chang S et al. Acquisition of spores on gloved hands after contact with the skin of patients with Clostridium difficile infection and with environmental surfaces in their rooms. Am J Infect Control 2012; 40:556–558 [View Article]
     [Google Scholar]
  21. Oughton MT, Loo VG, Dendukuri N, Fenn S, Libman MD. Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile . Infect Control Hosp Epidemiol 2009; 30:939–944 [View Article]
     [Google Scholar]
  22. Dubberke ER, Carling P, Carrico R, Donskey CJ, Loo VG et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014; 35:628–645 [View Article]
     [Google Scholar]
  23. Galvin S, Dolan A, Cahill O, Daniels S, Humphreys H. Microbial monitoring of the hospital environment: why and how?. J Hosp Infect 2012; 82:143–151 [View Article]
     [Google Scholar]
  24. Dey BP, Engley FB. Methodology for recovery of chemically treated Staphylococcus aureus with neutralizing medium. Appl Environ Microbiol 1983; 45:1533–1537 [View Article]
     [Google Scholar]
  25. Cadnum JL, Hurless KN, Deshpande A, Nerandzic MM, Kundrapu S et al. Sensitive and selective culture medium for detection of environmental Clostridium difficile isolates without requirement for anaerobic culture conditions. J Clin Microbiol 2014; 52:3259–3263 [View Article]
     [Google Scholar]
  26. Eckert C, Burghoffer B, Lalande V, Barbut F. Evaluation of the chromogenic agar chromID C. difficile . J Clin Microbiol 2013; 51:1002–1004 [View Article]
     [Google Scholar]
  27. Wren M. Clostridium difficile isolation and culture techniques. Methods Mol Biol 2010; 646:39–52
     [Google Scholar]
  28. Lemee L, Dhalluin A, Testelin S, Mattrat MA, Maillard K et al. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (toxin A), and tcdB (toxin B) genes for toxigenic culture of Clostridium difficile . J Clin Microbiol 2004; 42:5710–5714 [View Article]
     [Google Scholar]
  29. Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B et al. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile . FEMS Microbiol Lett 2000; 186:307–312 [View Article]
     [Google Scholar]
  30. Borren NZ, Ghadermarzi S, Hutfless S, Ananthakrishnan AN. The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact. PLoS One 2017; 12:e0176797 [View Article]
     [Google Scholar]
  31. Martirosian G, Szczęsny A, Silva J. Clostridium difficile in emergency room. Anaerobe 2005; 11:258–261 [View Article]
     [Google Scholar]
  32. Martirosian G. Recovery of Clostridium difficile from hospital environments. J Clin Microbiol 2006; 44:1202–1203 [View Article]
     [Google Scholar]
  33. Dumford DM, Nerandzic MM, Eckstein BC, Donskey CJ. What is on that keyboard? detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains. Am J Infect Control 2009; 37:15–19 [View Article]
     [Google Scholar]
  34. Aktories K. Rho proteins: targets for bacterial toxins. Trends Microbiol 1997; 5:282–288 [View Article]
     [Google Scholar]
  35. Di BS, Ascenzi P, Siarakas S, Petrosillo N, Masi A. Clostridium difficile Toxins A and B: insights into pathogenic properties and extraintestinal effects. Toxins 2016; 8:134
     [Google Scholar]
  36. Seugendo M, Mshana SE, Hokororo A, Okamo B, Mirambo MM et al. Clostridium difficile infections among adults and children in Mwanza/Tanzania: is it an underappreciated pathogen among immunocompromised patients in sub-Saharan Africa?. New Microbes New Infect 2015; 8:99–102 [View Article]
     [Google Scholar]
  37. Plants-Paris K, Bishoff D, Oyaro MO, Mwinyi B, Chappell C et al. Prevalence of Clostridium difficile infections among Kenyan children with diarrhea. Int J Infect Dis 2019; 81:66–72 [View Article]
     [Google Scholar]
  38. Perelle S, Gibert M, Bourlioux P, Corthier G, Popoff MR. Production of a complete binary toxin (actin-specific ADP- Ribosyltransferase) by Clostridium difficile CD196. Infect Immun 1997; 65:1402–1407 [View Article]
     [Google Scholar]
  39. Godinho L-A, Feldman C. Clostridium difficile infection in Johannesburg, South Africa. Hosp Pract 2018; 46:287–294 [View Article]
     [Google Scholar]
  40. Dubberke ER, Reske KA, Noble-Wang J, Thompson A, Killgore G et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control 2007; 35:315–318 [View Article]
     [Google Scholar]
  41. Dyer C, Hutt PL, Burky R, Joshi TL. Biocide resistance and transmission of Clostridium difficile spores spiked onto clinical surfaces from an American Health Care Facility. Appl Environ Microbiol 2019; 85:1–11 [View Article]
     [Google Scholar]
  42. Marufu O, Desai N, Aldred D, Brown T, Eltringham I. Analysis of interventions to reduce the incidence of Clostridium difficile infection at a London teaching hospital trust, 2003‒2011. J Hosp Infect 2015; 89:38–45 [View Article]
     [Google Scholar]
/content/journal/acmi/10.1099/acmi.0.000171
Loading
High levels of toxigenic Clostridioides difficile contamination of hospital environments: a hidden threat in hospital-acquired infections in Kenya
Access Microbiology 2, e000171 (2020); https://doi.org/10.1099/acmi.0.000171
/content/journal/acmi/10.1099/acmi.0.000171
/content/journal/acmi/10.1099/acmi.0.000171
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error